	Breaking resistance barriers: ensartinib as a milestone in anaplastic lymphoma kinase-driven non-small cell lung cancer therapy. Naunyn Schmiedebergs Arch Pharmacol Gumma L, Gumma B, Yarrabothula LP. PMID: 41670693 [PubMed - as supplied by publisher]
	ASH 2026 Guidelines for Frontline Management of Acute Lymphoblastic Leukemia in Adolescents and Young Adults. Blood Adv DuVall AS, McNeer J, Cheung MC, Adrianzen-Herrera DA, Advani AS, Aljurf M, Audino AN, Benitez L, Deeter A, Dworkin E, Hiltbrand OS, Isenalumhe LL, Li L, Miller-Chism CN, Mozessohn L, Ng AP, Pu JJ, Shafer D, Vargas Madueno F, Viny AD, Wadhwa A, Yang J, Zarnegar-Lumley S, Mai HJ, Kanaan G, Sereda Y, Saldanha IJ, Balk EM, Stock WA, Wolfson JA. PMID: 41670627 [PubMed - as supplied by publisher]
	Clinicopathological Characteristics and Prognostic Factors in Angioimmunoblastic T-cell Lymphoma: a Retrospective Analysis. Clin Lab Wang J, Guo L. PMID: 41670524 [PubMed - indexed for MEDLINE]
	A Rare Case of Acute Promyelocytic Leukemia with ider(17)(q10)t(15;17)(q22;q21) and FLT3-ITD Mutation. Clin Lab Lee JH. PMID: 41670515 [PubMed - indexed for MEDLINE]
	A Case of Primary IgG-Îº with Îº Free Light Chain Plasma Cell Leukemia with Literature Review. Clin Lab Ma Q, Zhang S, Qin W. PMID: 41670499 [PubMed - indexed for MEDLINE]
	Considerations on the Diagnosis and Prognosis of Primary Cardiac Lymphoma. Arq Bras Cardiol Almeida TG, Oliveira TGF, Soares GDS, Tenório PP. PMID: 41670127 [PubMed - in process]
	Exploratory association of muscle and adipose tissue indices with clinical outcomes in aggressive lymphomas. Cancer Mantz L, Johnson PC, Lei M, Newcomb RA, Stacey J, Yang D, Coffey B, Markovitz N, Venkatachalam S, Kim E, Rahman T, El-Jawahri A, Odejide OO, Fintelmann FJ. PMID: 41669999 [PubMed - indexed for MEDLINE]
	Pulmonary Mucosa-Associated Lymphoid Tissue Lymphoma and Tuberculosis: A Rare Association With Diagnostic and Therapeutic Challenges. J Med Cases Del Val Talens A, Balague O, Rodriguez S, Del Rio A, Rivero A, Mozas P, Correa J, Gine E, Lopez-Guillermo A, Garcia F, Soriano A, Magnano L. PMID: 41669645 [PubMed]
	Case report: A case of mast cell leukemia treated with avapritinib: from diagnostic challenge to transplantation. Front Oncol Faraci DG, Caravelli D, Schianca FC, Zaniol E, Enrico F, Boffano C, Labate C, Sterpi G, Fornari A, Sangiorgio V, Crisà E. PMID: 41669109 [PubMed]
	Nivolumab Maintenance for Aggressive B-Cell Lymphoma in Remission After First Line Therapy: A Phase 2 Clinical Trial. Eur J Haematol Kedmi M, Ribakovsky E, Porges T, Benjamini O, Shimoni A, Avigdor A. PMID: 41668621 [PubMed - as supplied by publisher]
	Characteristics and prognosis of Epstein Barr virus-positive diffuse large B-cell lymphoma: a retrospective, single-center study. Hematology Qiaochu L, Lianming L, Jianzhen S, XiaoFeng L, Haiying F, Tingbo L. PMID: 41668558 [PubMed - indexed for MEDLINE]
	Efficacy and safety of 50Â mg versus 100Â mg daily frontline dasatinib therapy in chronic-phase chronic myeloid leukemia: a non-controlled, observational dose-comparative cohort study. BMC Cancer Cheng F, Wang F, Cui Z, Li Q, Zhu Y, Li W. PMID: 41668074 [PubMed - as supplied by publisher]
	Severe toxicity-free survival following acute lymphoblastic leukemia in patients aged 1-45 years: a Danish cohort study. Leukemia Nielsen CG, Als-Nielsen B, Albertsen BK, Davídsson ÓB, Dimitrijevic A, Hjalgrim H, Ifversen M, Lundgren L, Lynggaard LS, Olsen M, Overgaard UM, Rank CU, Rathe M, Rostgaard K, Schmiegelow K, Andrés-Jensen L. PMID: 41667647 [PubMed - as supplied by publisher]
	Author Correction: Whole-body CD8(+) T-cell PET imaging in patients with large B-cell lymphoma before and during CD19-directed CAR T-cell therapy: a phase 2 study. Nat Commun de Boer JW, Keijzer K, van Doesum JA, Smit NAM, Brouwers AH, van Sluis J, Lub-de Hooge MN, Pierik FR, Huls GA, van Dijk LV, Visser L, Diepstra A, Noordzij W, Williams SP, Ungewickell A, Elias SG, de Vries EGE, Niezink AGH, van Meerten T. PMID: 41667465 [PubMed - in process]
	Effectiveness of a Positive Psychological Intervention Based on the PERMA Model on Fear of Disease Progression in Parents of Children with Acute Leukemia. Semin Oncol Nurs Li X, Cao S, Guo F, Zhang Y, Yu J, Cui L. PMID: 41667353 [PubMed - as supplied by publisher]
	Cellular and Novel Immunotherapies for Classic Hodgkin Lymphoma. Hematol Oncol Clin North Am Reef DK, Grover NS. PMID: 41667304 [PubMed - as supplied by publisher]
	New Developments in Hodgkin's Lymphoma: Outcomes and Disparities in Classic Hodgkin Lymphoma. Hematol Oncol Clin North Am Crisler KM, Heneghan MB, Kahn JM. PMID: 41667302 [PubMed - as supplied by publisher]
	Associations of maternal education with suggested childhood cancer risk factors: Findings from the Childhood Cancer and Leukemia International Consortium (CLIC). Cancer Epidemiol Dolatkhah R, Erdmann F, Bouaoun L, Mueller BA, Petridou ET, Schraw JM, Kane E, Marcotte EL, Force LM, Dockerty JD, Moissonnier M, Olsson A, Roman E, Clavel J, Metayer C, Magnani C, Mora AM, Rashed WM, Chow EJ, Bonaventure A, Kang AY, Miligi L, Scheurer ME, Spector LG, Schüz J. PMID: 41666504 [PubMed - as supplied by publisher]
	Adverse karyotype amplifies risk in secondary acute myeloid leukemia (AML) and AML with myelodysplasia-related changes. Hematology Matsukawa T, Yoshida S, Onozawa M, Fujii F, Nagai J, Takahashi T, Ota S, Hashiguchi J, Mori A, Miyagishima T, Ibata M, Kakinoki Y, Oyake T, Yamamoto S, Hayashi T, Wakasa K, Saga T, Igarashi T, Iyama S, Tsutsumi Y, Fujimoto K, Adachi M, Yoshida M, Hashimoto D, Teshima T. PMID: 41666291 [PubMed - indexed for MEDLINE]
	Epiregulin levels and their association with prognostic factors in Hodgkin lymphoma: a case-control study. Ann Hematol Yildirim Akan Ö, Demir , Bilgir F, Bozkaya G, Ceylan , Bilgir O. PMID: 41665716 [PubMed - in process]

Articles 1 - 20 / 165883

Page 1 of 8295



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy